Insider Trading Alert - HEB, EPAY And STOR Traded By Insiders

Yesterday, March 14, 2016, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $5.92 to $72,390,000.00.

Highlighted Stocks Traded by Insiders:

Hemispherx Biopharma (HEB) - FREE Research Report

Equels Thomas K., who is CEO,Pres,Exec Vice Chairman at Hemispherx Biopharma, bought 40,000 shares at $0.16 on March 14, 2016. Following this transaction, the CEO,Pres,Exec Vice Chairman owned 10,000 shares meaning that the stake was boosted by 133.33% with the 40,000-share transaction.

The shares most recently traded at $0.16, up $0.00, or 1.38% since the insider transaction. Historical insider transactions for Hemispherx Biopharma go as follows:

  • 4-Week # shares bought: 30,000
  • 12-Week # shares bought: 30,000
  • 24-Week # shares bought: 30,000

The average volume for Hemispherx Biopharma has been 844,500 shares per day over the past 30 days. Hemispherx Biopharma has a market cap of $39.6 million and is part of the health care sector and drugs industry. Shares are up 98.39% year-to-date as of the close of trading on Monday.

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. Currently, there are no analysts who rate Hemispherx Biopharma a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HEB - FREE

TheStreet Quant Ratings rates Hemispherx Biopharma as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full Hemispherx Biopharma Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Bottomline Technologies (EPAY) - FREE Research Report

Mcgurl Daniel M, who is Director at Bottomline Technologies, sold 15,000 shares at $28.48 on March 14, 2016. Following this transaction, the Director owned 37,000 shares meaning that the stake was reduced by 28.85% with the 15,000-share transaction.

The shares most recently traded at $28.64, up $0.16, or 0.55% since the insider transaction. Historical insider transactions for Bottomline Technologies go as follows:

  • 4-Week # shares sold: 23,394
  • 12-Week # shares sold: 27,030
  • 24-Week # shares sold: 35,370

The average volume for Bottomline Technologies has been 254,300 shares per day over the past 30 days. Bottomline Technologies has a market cap of $1.2 billion and is part of the technology sector and computer software & services industry. Shares are down 2.52% year-to-date as of the close of trading on Monday.

Bottomline Technologies (de), Inc. provides hosted or software as a service solutions for various industries worldwide. Currently, there are 3 analysts who rate Bottomline Technologies a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EPAY - FREE

TheStreet Quant Ratings rates Bottomline Technologies as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. Get the full Bottomline Technologies Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

STORE Capital (STOR) - FREE Research Report

STORE Holding Company, LLC, who is Director at STORE Capital, sold 3.0 million shares at $24.13 on March 14, 2016. Following this transaction, the Director owned 33.3 million shares meaning that the stake was reduced by 8.26% with the 3.0 million-share transaction.

The shares most recently traded at $24.92, up $0.79, or 3.17% since the insider transaction. Historical insider transactions for STORE Capital go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 20.0 million
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 34.0 million
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 36.1 million

The average volume for STORE Capital has been 1.4 million shares per day over the past 30 days. STORE Capital has a market cap of $3.5 billion and is part of the financial sector and real estate industry. Shares are up 7.72% year-to-date as of the close of trading on Monday.

STORE Capital is a privately owned real estate investment trust. The firm invests in the real estate markets. It primarily invests in single-tenant properties including chain restaurants, supermarkets, drugstores and other retail, service and distribution facilities. The stock currently has a dividend yield of 4.33%. The company has a P/E ratio of 36.7. Currently, there are 9 analysts who rate STORE Capital a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on STOR - FREE

TheStreet Quant Ratings rates STORE Capital as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full STORE Capital Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.